)
We believe completing clinical research and partnering with regulatory authorities is the best approach to improving health outcomes for people with an illness or disease. To date, Acadia has not supported, nor provided any of our treatments for expanded access, named patient or compassionate use programmes that offer patients access to our treatments prior to regulatory approvals.
For general inquiries, including questions related to our clinical research or products, please contact Acadia at medicalinformationglobal@acadia-pharm.com.